CRO

Quintiles pools postmarketing services into a single offering

Quintiles ($Q) has unveiled a new offering that combines its pharmacovigilance, label management, risk-benefit research and analytics into a single product, touting the service as a catch-all for approved drugs. The new platform, called Marketed Product Maintenance, is designed to provide all the data-driven information clients need to get the most out of their products, Quintiles said, handling postapproval requirements to boost return on investment. More